Skip to content

Euphora™ EUP27515XRecalls & reported problems

Medtronic, Inc. · BALLOON EUP27515X EUPHORA RX US · Class 2

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
2

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00643169560093), received between Sep 17, 2021 and Sep 17, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Deflation Problem” (1 report).

2 FDA recall records name this device's identifier, 1 still open.

1 other recall cover devices cleared under the same FDA submission (K143480); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Recalls naming this device

  1. Sep 3, 2019Open, Classified

    Medtronic has determined that some catheters have a slightly higher diameter stylette causing removal difficulties.

    Z-0122-2020 · Root cause: Under Investigation by firm · FDA record ↗

  2. Jul 13, 2017Terminated

    Stylette removal difficulties on the Euphora and Solarice products.

    Z-3136-2017 · Root cause: Process design · FDA record ↗

Most reported problems

Device problems

  • Deflation Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 17, 2021Deflation Problem; Deflation Problem

    ONE EUPHORA RX BALLOON CATHETER WAS ATTEMPTED TO BE USED TO PRE-DILATE A MILDLY TORTUOUS, MODERATELY CALCIFIED LESION WITH 90% STENOSIS IN THE PROXIMAL LEFT ANTERIOR DESCENDING (LAD) ARTERY. THE DEVICE WAS INSPECTED WITH NO ISSUES NOTED. NEGATIVE PREP WAS PERFORMED WITH NO ISSUES NOTED. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT. RESISTANCE WAS NOT ENCOUNTERED WHEN ADVANCING THE DEVICE AND EXCESSIVE FORCE WAS NOT USED. THE BALLOON WAS INFLATED TO NOMINAL PRESSURE WITHOUT EXCEEDING THE RATED BURST PRESSURE (RBP). IT WAS REPORTED THAT THE BALLOON FAILED TO DEFLATE AT THE LESION SITE AFTER PRE-DILATING THE LESION. THE BALLOON WAS ABLE TOBE REMOVED OVER THE WIRE THROUGH THE GUIDE CATHETER AND OUT OF THE SHEATH WITHOUT ANY ISSUES. NO PATIENT INJURY REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12487330 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K143480. One submission often covers many models, so check the product and lot details in each record.

  • Z-3137-2017 · Jul 13, 2017 · Terminated
    Solarice Rapid Exchange Balloon Dilatation Catheter, a Percutaneous Transluminal Coronary Angioplasty (PTCA) Rapid Exchange System.

Other Catheters, transluminal coronary angioplasty, percutaneous devices

All Catheters, transluminal coronary angioplasty, percutaneous devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.